Rae Thomas & Paul Glasziou
Rae Thomas is an Associate Professor within the Institute of Evidence-Based Healthcare at Bond University. Previously, she spent over 25 years as a psychologist working with adults and children. Her research interests are embedding public voices in health guidelines and policy and translating research evidence to practice and policy.
Paul Glasziou is Professor of Evidence-Based Medicine and Director of the Institute of Evidence-Based Healthcare at Bond University. He was the Director of the Centre for Evidence-Based Medicine in Oxford from 2003-2010, and a part-time General Practitioner. His key interests include identifying and removing the barriers to using high quality research in everyday clinical practice.
Paul Glasziou is Professor of Evidence-Based Medicine and Director of the Institute of Evidence-Based Healthcare at Bond University. He was the Director of the Centre for Evidence-Based Medicine in Oxford from 2003-2010, and a part-time General Practitioner. His key interests include identifying and removing the barriers to using high quality research in everyday clinical practice.
“I was very upset to be diagnosed”: The psychosocial impact of a diagnosis of gestational diabetes
While the harms of gestational diabetes are well-known, along with the physical benefits of diagnosing and treating it early, the psychosocial harms of a diagnosis are less well-understood. In light of controversial changes to the diagnostic criteria for gestational diabetes, the authors of a new systematic review of qualitative studies, published in BMC Pregnancy and Childbirth, discuss balancing these benefits and harms and how their research should be used to inform future updates to the criteria.
Benefits and harms of diagnosis
For people with painful or disruptive symptoms, a medical diagnosis can have emotional and tangible benefits such as peace of mind from having a ‘known cause’ of the symptoms, social support, access to funded services, and knowledge of treatment options. But diagnostic labels can also have harms, such as levels of distress, a change in perceived control over one’s own health, and reductions to health service access. All diagnostic labels have different benefits and harms for different groups, but the harms are particularly an issue for people with no symptoms – they may experience the harms with no benefit. This can happen when we screen for diseases before symptoms are felt, such screening for vitamin D deficiency or the current thought to screen all adolescents for depression.
No hay comentarios:
Publicar un comentario